67% found this document useful (3 votes)
18K views1 page

Breast Cancer Report Sample High en

1) The patient's tumor marker levels suggest malignancy based on an absence of comorbidities that could cause false positives. 2) Based on the tumor marker results, the conclusion is to suggest breast cancer with an ICD-10 code of C50, which indicates malignant neoplasm of the breast. 3) The report provides the results of a multiple biomarker disease activity algorithm for breast cancer developed as a clinical decision support system, with sensitivities and specificities listed.

Uploaded by

Nishant Kini
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
67% found this document useful (3 votes)
18K views1 page

Breast Cancer Report Sample High en

1) The patient's tumor marker levels suggest malignancy based on an absence of comorbidities that could cause false positives. 2) Based on the tumor marker results, the conclusion is to suggest breast cancer with an ICD-10 code of C50, which indicates malignant neoplasm of the breast. 3) The report provides the results of a multiple biomarker disease activity algorithm for breast cancer developed as a clinical decision support system, with sensitivities and specificities listed.

Uploaded by

Nishant Kini
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1

0 0 0 0 0 0 0 0 0 0 9 0

OncoBREAST Dx - Final Report

Patient Information

Identification Data General Biochemistry Blood Drawn Realization


HRN: BRE00000273 Creatinine (mg/dL): 1.00 Blood Drawn Date: 11-10-2017
ID Card: Unknown ASAT (U/L): 8.00
ALAT (U/L): 12.00 Urine Tumor Markers
Personal Data GGT (U/L): 7.00 8-OHdG (ng/mL): 11.10
Age (years): 47 Total Bilirubin (mg/dL): 1.00
Hemolized Sample: No Urine Drawn Realization
Comorbidities Urine Drawn Date: 11-10-2017
Atherosclerosis: No Serum Tumor Markers
Chronic Liver Disease: No CA 15.3 (U/mL): 19.70 Lifestyle
Diabetes Mellitus 1 or 2: No CEA (ng/mL): 1.60 Smoking: Currently
Jaundice: No EGFR (ng/mL): 5.00
Renal Failure: No NGAL (ng/mL): 4.60
NSE (ng/mL): 7.00

Outcome

Results
Some Tumor Markers are outside the reference range and suggest malignancy.

Comments
In absence of comorbidities that are well-known source of False Positive (FP) in healthy patients by
increasing some Tumor Markers levels, whole Tumor Markers levels suggest malignancy.

Conclusions
WE SUGGEST BREAST CANCER. THE 2016 ICD-10-CM DIAGNOSIS CODE IS C50 (MALIGNANT NEOPLASM
OF BREAST).

This report has been generated from the data entered on 19-12-2017 10:55:02 UTC/GMT.

Disclaimer
This Multiple Biomarkers Disease Activity Algorithm (MBDAA) for Breast Cancer has been developed for
the exclusive use by healthcare professionals, and solely as a Clinical Decision Support System (CDSS),
not as an unique element for diagnosis. The algorithm bears a Sensitivity = 82.3%, Specificity = 85.7%.
Please note, negativity of the Tumor Markers does not exclude at 100% the possibility of a malignant
epithelial tumor.

Bioprognos SL Technical Responsible


Benet Mateu, 40 - 08034 Barcelona (Spain) Lorena Lendinez
Email: [email protected] Chief Scientific Officer
Website: www.bioprognos.com Bioprognos SL

Powered by TCPDF (www.tcpdf.org)

You might also like